222 related articles for article (PubMed ID: 10773551)
21. Application of high affinity binding concept to radiolabel avidin with Tc-99m labeled biotin and the effect of pI on biodistribution.
Jeong JM; Kinuya S; Paik CH; Saga T; Sood VK; Carrasquillo JA; Neumann RD; Reynolds JC
Nucl Med Biol; 1994 Oct; 21(7):935-40. PubMed ID: 9234347
[TBL] [Abstract][Full Text] [Related]
22. Effect of protein binding on renal extraction of 131I-OIH and 99mTc-labeled tubular agents.
Eshima D; Eshima L; Hansen L; Lipowska M; Marzilli LG; Taylor A
J Nucl Med; 2000 Dec; 41(12):2077-82. PubMed ID: 11138695
[TBL] [Abstract][Full Text] [Related]
23. Influence of the denticity of ligand systems on the in vitro and in vivo behavior of (99m)Tc(I)-tricarbonyl complexes: a hint for the future functionalization of biomolecules.
Schibli R; La Bella R; Alberto R; Garcia-Garayoa E; Ortner K; Abram U; Schubiger PA
Bioconjug Chem; 2000; 11(3):345-51. PubMed ID: 10821650
[TBL] [Abstract][Full Text] [Related]
24. Comparison of technetium-99m-ll-EC isomers in rats and humans.
Taylor A; Hansen L; Eshima D; Malveaux E; Folks R; Shattuck L; Lipowska M; Marzilli LG
J Nucl Med; 1997 May; 38(5):821-6. PubMed ID: 9170454
[TBL] [Abstract][Full Text] [Related]
25. Role of technetium-99m N,N-ethylenedicysteine renal scintigraphy in the evaluation of differential renal function and cortical defects.
Buyukdereli G; Guney IB
Clin Nucl Med; 2006 Mar; 31(3):134-8. PubMed ID: 16495730
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the renal excretion characteristics of technetium-99m mercaptoacetylglycyl-D-alanylglycine in healthy volunteers.
Bormans GM; Cleynhen BJ; De Roo MJ; Verbruggen AM
Eur J Nucl Med; 1992; 19(4):271-7. PubMed ID: 1534544
[TBL] [Abstract][Full Text] [Related]
27. Technetium-99m ethylene dicysteine: a new renal tubular function agent.
Kabasakal L
Eur J Nucl Med; 2000 Mar; 27(3):351-7. PubMed ID: 10774890
[TBL] [Abstract][Full Text] [Related]
28. Technetium-99m-L,L-ethylenedicysteine is more effective than technetium-99m diethylenetriamine penta-acetic acid for excluding obstruction in patients with pyelocalicinal dilation.
Lima MC; de Lima ML; Pepe CF; Etchebehere EC; Santos AO; Amorim BJ; Camargo EE; Ferreira U; Palma PC; Ramos CD
Urology; 2010 Aug; 76(2):283-8. PubMed ID: 20206974
[TBL] [Abstract][Full Text] [Related]
29. Technetium-99m labeling of N-[N-(3-diphenylphosphino propionyl)glycyl]cysteine (PN2S-OH) and its methyl ester derivative (PN2S-OMe).
Visentin R; Giron MC; Bello M; Mazzi U
Nucl Med Biol; 2004 Jul; 31(5):655-62. PubMed ID: 15219285
[TBL] [Abstract][Full Text] [Related]
30. Reproducibility of technetium-99m ethylenedicysteine clearance.
Kabasakal L; Halaç M; Alkan E; Ozçelik N; Uslu I
Eur J Nucl Med; 1999 Aug; 26(8):900-2. PubMed ID: 10436204
[TBL] [Abstract][Full Text] [Related]
31. Preclinical evaluation of 99mTc(CO)3-aspartic-N-monoacetic acid, a renal radiotracer with pharmacokinetic properties comparable to 131I-o-iodohippurate.
Lipowska M; Klenc J; Marzilli LG; Taylor AT
J Nucl Med; 2012 Aug; 53(8):1277-83. PubMed ID: 22717977
[TBL] [Abstract][Full Text] [Related]
32. Complexes of technetium-99m with tetrapeptides, a new class of 99mTc-labelled agents.
Vanbilloen HP; Bormans GM; De Roo MJ; Verbruggen AM
Nucl Med Biol; 1995 Apr; 22(3):325-38. PubMed ID: 7627148
[TBL] [Abstract][Full Text] [Related]
33. The utility of (99m)Tc-DMSA and Tc(99m)-EC scintigraphy for early diagnosis of ifosfamide induced nephrotoxicity.
Caglar M; Yarís N; Akyuz C
Nucl Med Commun; 2001 Dec; 22(12):1325-32. PubMed ID: 11711903
[TBL] [Abstract][Full Text] [Related]
34. Clinical comparison of technetium-99m-EC, technetium-99m-MAG3 and iodine-131-OIH in renal disorders.
Kabasakal L; Turoğlu HT; Onsel C; Ozker K; Uslu I; Atay S; Cansiz T; Sönmezoğlu K; Altiok E; Isitman AT
J Nucl Med; 1995 Feb; 36(2):224-8. PubMed ID: 7830118
[TBL] [Abstract][Full Text] [Related]
35. Formulation and evaluation of a single vial lyophilized preparation of technetium-99m labeled ethylene dicysteine as a renal scintigraphic agent.
Sohaib M; Afshan A; Saeed S; Khalid MA; Yousuf M
Pak J Pharm Sci; 2014 Sep; 27(5):1287-94. PubMed ID: 25176364
[TBL] [Abstract][Full Text] [Related]
36. Technetium-99m-L,L-ethylenedicysteine renal scan as a single-modality investigation for the evaluation of renal morphology and function: a comparative study with technetium-99m-dimercaptosuccinic acid.
Narayana C; Tripathi M; Kumar A; Gowda NK; Phom H; Chandra P; Bandopadhyaya G; Bal C
Nucl Med Commun; 2004 Jul; 25(7):743-7. PubMed ID: 15208504
[TBL] [Abstract][Full Text] [Related]
37. Technetium-99m-N,N-ethylenedicysteine--a comparative study of renal scintigraphy with technetium-99m-MAG3 and iodine-131-OIH in patients with obstructive renal disease.
Ozker K; Onsel C; Kabasakal L; Sayman HB; Uslu I; Bozluolçay S; Cansiz T; Kapicioğlu T; Urgancioğlu I
J Nucl Med; 1994 May; 35(5):840-5. PubMed ID: 8176468
[TBL] [Abstract][Full Text] [Related]
38. The value of different washout parameters in the evaluation of renal transplants by technetium-99m-ethylene- l-l-dicysteine.
Kanmaz B; Sayman HB; Alan N; Devranoglu G; Nisli S; Sonmezoglu K; Kabasakal L; Halac M; Onsel C; Uslu I
Hell J Nucl Med; 2010; 13(2):127-31. PubMed ID: 20808985
[TBL] [Abstract][Full Text] [Related]
39. Comparison of Tc-99m EC and Tc-99m DTPA captopril scintigraphy to diagnose renal artery stenosis.
Uğur O; Serdengeçti M; Karaçalioğlu O; Peksoy I; Cekirge S; Aslan N; Ergün EL; Duranay M; Yurdakul M; Caner B; Bayhan H
Clin Nucl Med; 1999 Aug; 24(8):553-60. PubMed ID: 10439173
[TBL] [Abstract][Full Text] [Related]
40. [(186/188)Re] rhenium-ethylene dicysteine (Re-Ec): preparation and evaluation for possible use in endovascular brachytherapy.
Das T; Banerjee S; Samuel G; Kothari K; Unni PR; Sarma HD; Ramamoorthy N; Pillai MR
Nucl Med Biol; 2000 Feb; 27(2):189-97. PubMed ID: 10773549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
